aTyr Pharma | LIFE - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
aTyr Pharma USD 110.08M 109.89M 2025-12
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Curis USD 1.14M 1.41M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Grifols EUR 2.34B 33.3M 2026-03
Novartis USD 13.11B 226M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Xoma USD 25K 5M 2024-09